查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762546

藥用小瓶市場：產業趨勢及全球預測 - 按所用製造材料類型、滅菌狀態和主要地區劃分

Pharmaceutical Vials Market: Industry Trends and Global Forecasts - Distribution by Type of Fabrication Material Used, Sterilization Status and Key Geographies
出版日期: | 出版商: Roots Analysis | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

藥用小瓶市場：概覽

今年全球藥用小瓶市場規模達110.3億美元。預計預測期內，該市場的年複合成長率將達到6%。

市場規模與機會分析依下列參數細分：

使用的製造材料種類

  • 玻璃
  • 塑膠

無菌狀態

  • 預無菌
  • 非無菌

主要地區

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和北非
  • 世界其他地區

藥用玻璃瓶市場：成長與趨勢

藥用玻璃瓶等初級包裝材料在維持藥品的穩定性、有效性和安全性方面發揮著非常重要的作用，因為它們與包裝中的治療藥物直接接觸。此外，藥品內包裝材料有助於保持藥品的無菌性和品質，同時提供與其身份相關的資訊，在某些情況下還提供給藥說明。此外，對腸外製劑的需求旺盛以及疫苗接種活動的日益增多，迫切需要安全優質的藥瓶來大量儲存此類製劑並在全球範圍內分銷。

藥瓶市場-IMG1

儘管傳統藥瓶是最受歡迎的包裝系統，但它也經常面臨一些挑戰，例如在惡劣條件下可能破損、包裝上缺少相關資訊（序號和批號）以及可能出現分層。因此，一些藥瓶製造商探索新技術，以克服傳統藥瓶面臨的上述挑戰，並提出更好的包裝解決方案。事實上，藥瓶製造商不斷創新，推出更新、更優的包裝解決方案，以滿足下一代藥物不斷變化的需求。該領域的進步包括預滅菌藥瓶的使用、多種塗層材料的開發以及智慧藥物傳輸技術的採用。

藥瓶市場：關鍵洞察

本報告分析了全球藥瓶市場的現狀，並探討了產業內的潛在成長機會。報告的主要調查結果包括：

  • 目前，近 95 家製造商銷售/開發了 240 多種藥瓶，其中大多數位於北美和歐洲等已開發國家。
  • 大多數藥瓶由玻璃製成，容量各異。
藥瓶市場-IMG2
  • 由於玻璃具有多種優勢，已成為藥瓶製造的首選材料。常用的玻璃類型包括I型硼矽酸鹽玻璃（65%）和III型鈉鈣玻璃（16%）。
  • 大多數藥瓶（60%）的容量小於50毫升，只有少數（8%）的容量超過100毫升。
  • 超過 60%的藥用小瓶設計為與螺旋蓋配合使用，此類小瓶包括 1-Clic® 小瓶系統、CryoClear™ 小瓶、NextGen™ V-Vial®、Pyrofree 小瓶、無菌 CryoSure® 小瓶等。
  • 為了打造競爭優勢，業內企業積極升級現有產能並增加新功能，以增強各自的產品組合。
  • 多年來，業內企業進一步開發了自己的藥用小瓶，並達成了多項協議以實現改進。
  • 過去幾年，該領域的合作活動以超過 30%的年複合成長率成長。
  • 現有企業和新進者過去都建立了策略夥伴關係。
  • 當前的行業趨勢證實了對創新包裝解決方案日益成長的需求，主要是為了滿足日益複雜的藥品大規模、專業化的生產和包裝要求。
  • 近40家公司聲稱提供各種具有不同自由度的機器人，為提高生產力和最佳化成本提供了顯著的機會。
  • 在COVID-19疫情期間，藥瓶的需求量很大，用於大量儲存和包裝新型疫苗和實驗性療法。
藥瓶市場-IMG3
  • 預計藥瓶的市場機會將均勻分佈在各種製造材料、無菌條件和地理區域。

藥用小瓶市場參與者

  • Chongqing Zhengchuan Pharmaceutical Packaging
  • Corning
  • DANYANG XIANGHE PHARMACEUTICAL PACKAGING
  • DWK Life Sciences
  • Gerresheimer
  • Ningbo Zhengli Pharmaceutical Packaging
  • Nipro
  • Origin Pharma Packaging
  • Pacific Vial Manufacturing
  • SCHOTT
  • SGD Pharma
  • Shandong Pharmaceutical Glass
  • Stevanato Group
  • Thermo Fisher Scientific
  • Worldwide Glass Resources

目錄

第1章 簡介

第2章 執行摘要

第3章 導論

  • 章節概述
  • 藥品包裝
  • 藥瓶
  • 藥瓶的創新

第4章 市場格局

  • 章節概述
  • 藥瓶：市場版圖
  • 藥瓶：製造商列表

第5章 公司競爭力分析

  • 章節概述
  • 假設和關鍵參數
  • 研究方法
  • 藥瓶：公司競爭力分析

第6章 公司簡介：北美藥瓶製造商

  • 章節概述
  • Corning
  • DWK Life Sciences
  • Pacific Vial Manufacturing
  • Thermo Fischer Scientific
  • Worldwide Glass Resources

第7章 公司簡介：歐洲藥瓶製造商

  • 章節概述
  • Gerresheimer
  • Origin Pharma Packaging
  • SCHOTT
  • SGD Pharma
  • Stevanato Group

第8章 公司簡介：亞太地區藥瓶製造商

  • Chongqing Zhengchuan Pharmaceutical Packaging
  • Danyang Xianghe Pharmaceutical Packaging
  • Ningbo Zhengli Pharmaceutical Packaging
  • Nipro
  • Shandong Pharmaceutical Glass

章節9 合作與合作

  • 章節概述
  • 合作模式
  • 藥瓶：合作夥伴關係與合作列表

第10章 藥品包裝的未來趨勢

  • 章節概述
  • 使用現代給藥裝置進行自我用藥的偏好
  • 努力開發改進的包裝組件並最佳化製造成本
  • 模組化設施的可用性
  • 對個人化治療的需求和偏好不斷成長
  • 填充和封口製程自動化的配置不斷增加
  • 合作關係活動激增
  • 發展中地區產業利害關係人的參與度不斷提高
  • 結論

第11章 需求分析

  • 章節概述
  • 範圍與研究方法論
  • 2035年全球藥用瓶需求
  • 結論

第12章 市場預測與機會分析

  • 章節概述
  • 預測研究方法與關鍵假設
  • 全球藥用瓶市場（～2035年）

第13章 案例研究：藥品包裝中的機器人技術

  • 章節概述
  • 機器人在製藥業中的作用
    • 選擇機器人系統時需要考慮的關鍵點
    • 機器人系統的優勢
    • 機器人系統的劣勢
  • 為製藥業提供機器人的公司
  • 為藥品包裝提供整合機器人系統的設備的公司
    • Aseptic Technologies
    • AST
    • Bosch Packaging Technology
    • Dara Pharmaceutical Packaging
    • Fedegari Group
    • IMA
    • Steriline
    • Vanrx Pharmasystems

第14章 案例研究：無菌/即用型藥瓶

  • 章節概述
  • 藥品包裝與填充
  • 傳統內包裝的局限性
  • 即用型內包裝
  • 結論

第15章 結論

第16章 高層洞察

第17章 附錄1：表格資料

第18章 附錄2：公司與組織清單

Product Code: RA100302

PHARMACEUTICAL VIALS MARKET: OVERVIEW

As per Roots Analysis, the global pharmaceutical vials market valued at USD 11.03 billion in the current year is anticipated to grow at a CAGR of 6% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Fabrication Material Used

  • Glass
  • Plastic

Sterilization Status

  • Pre-sterilized
  • Unsterilized

Key Geographies

  • North America
  • Europe
  • Asia- Pacific
  • Latin America
  • Middle East and North Africa
  • Rest of the World

PHARMACEUTICAL VIALS MARKET: GROWTH AND TRENDS

Primary packaging material such as pharmaceutical glass vials play a crucial role in preserving the stability, efficacy and safety of the drug as it is in direct contact with the packaged therapeutic. Additionally, pharmaceutical primary packaging material assists in maintaining the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Moreover, given the high demand for parenteral formulations and rising vaccination campaigns, there is an urgent need for safe and high-quality pharmaceutical vials, for storing and distributing such formulations in large quantities, across the world.

Pharmaceutical Vials Market - IMG1

Despite being the most preferred packaging system, traditional vials are often associated with certain challenges, including chances of breakage under extreme conditions, absence of relevant information (serial or batch number) on the package and potential to delaminate. As a result, several pharmaceutical vials manufacturers are exploring novel techniques to overcome the aforementioned challenges associated with conventional pharmaceutical vials in order to create better packaging solutions. In fact, pharmaceutical vial manufacturers are constantly innovating and creating newer and better packaging solutions in order to meet the changing demands of next generation drug products. Examples of some advancements in this domain include the use of pre-sterilized vials, development of numerous coating materials and adoption of smart drug delivery technologies.

PHARMACEUTICAL VIALS MARKET: KEY INSIGHTS

The report delves into the current state of the global pharmaceutical vials market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Presently, more than 240 pharmaceutical vials are available / being developed by close to 95 manufacturers; most of these players are based in the developed such as North America and Europe.
  • Majority of the pharmaceutical vials are fabricated using glass and are available in a variety of volumes; screw caps are amongst the preferred type of vial caps used for such containers.
Pharmaceutical Vials Market - IMG2
  • Owing to the various benefits, glass emerged as the most preferred fabrication material used for pharmaceutical vials; common types of glass used include type I borosilicate glass (65%) and type III soda-lime glass (16%).
  • Majority (60%) of the pharmaceutical vials have a capacity to hold less than 50 ml of drug product; however, very few (8%) vials are capable of storing more than 100 ml of therapeutic products.
  • More than 60% of the pharmaceutical vials are designed to be used with screw caps; examples of such vials include 1-Clic(R) Vial System, CryoClear(TM) vials, NextGen(TM) V-Vial(R), Pyrofree vials and Sterile CryoSure(R) Vial.
  • In pursuit of building a competitive edge, industry stakeholders are actively upgrading their existing capabilities and adding new competencies in order to enhance their respective product portfolios.
  • Over the years, industry players have established several deals to further advance the development / enable the improvement of their proprietary pharmaceutical vials.
  • The partnership activity in this domain has increased at a CAGR of over 30% in the past few years.
  • Both established players and new entrants have forged strategic partnerships in the recent past; acquisitions emerged as the prominent type of partnership model.
  • Current industry trends support the growing need for innovative packaging solutions, primarily to accommodate large scale and specialized production / packaging requirements of increasingly complex drug products.
  • Close to 40 players claim to provide a wide range of robotic machinery, having different degrees of freedom, offering notable productivity and cost optimization opportunities.
  • Pharmaceutical vials have been in high demand during the COVID-19 pandemic to store and package the novel vaccines and experimental therapies in large quantities.
Pharmaceutical Vials Market - IMG3
  • The estimated market opportunity for pharmaceutical vials is expected to be well distributed across different types of fabrication material, sterilization status and geographical regions.

Example Players in the Pharmaceutical Vials Market

  • Chongqing Zhengchuan Pharmaceutical Packaging
  • Corning
  • DANYANG XIANGHE PHARMACEUTICAL PACKAGING
  • DWK Life Sciences
  • Gerresheimer
  • Ningbo Zhengli Pharmaceutical Packaging
  • Nipro
  • Origin Pharma Packaging
  • Pacific Vial Manufacturing
  • SCHOTT
  • SGD Pharma
  • Shandong Pharmaceutical Glass
  • Stevanato Group
  • Thermo Fisher Scientific
  • Worldwide Glass Resources

PHARMACEUTICAL VIALS MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the pharmaceutical vials market, focusing on key market segments, including [A] type of fabrication material used, [B] sterilization status and [C] key geographies.
  • Market Landscape: A comprehensive evaluation of pharmaceutical vials, based on several relevant parameters, such as [A] type of fabrication material used for container, [B] type of fabrication material used for closure, [C] volume of vial, [D] type of vial cap, [D] sterilization status, [E] type of product, [F] compatible drug class and [G] type of formulation stored. Additionally, a comprehensive evaluation of pharmaceutical vial manufacturers based on several relevant parameters, including [A] year of establishment, [B] company size, [C] location of headquarters and [D] key players (in terms of number of products).
  • Company Competitiveness Analysis: A comprehensive competitive analysis of pharmaceutical vial manufacturers, examining factors, such as [A] supplier power and [B] key product specifications.
  • Company Profiles: In-depth profiles of the players engaged in the development of pharmaceutical vials, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the pharmaceutical vial domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of fabrication material involved, [D] sterilization status, [E] type of partners and [F] regional distribution of the partnerships.
  • Upcoming Trends in Pharmaceutical Packaging: An in-depth analysis of key trends that are likely to impact the future adoption of novel primary packaging systems. Further, a Harvey ball analysis, focusing on the relative effect of each trend on the overall pharmaceutical packaging industry.
  • Demand Analysis: A detailed analysis of the current and future demand for pharmaceutical vials, based on various parameters, such as [A] type of fabrication material used, [B] sterilization status and [C] regions.
  • Case Study: A detailed discussion on the use of robotic machinery in pharmaceutical manufacturing and fill / finish operations, describing the advantages of using automation / automated technologies in such processes.
  • Case Study: A detailed discussion on pre-sterilized / RTU pharmaceutical vials that are currently available. Additionally, the section discusses various sterilization techniques used for primary packaging materials and the advantages of RTU container-closure systems.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Pharmaceutical Packaging
    • 3.2.1. Need for Pharmaceutical Packaging
    • 3.2.2. Types of Pharmaceutical Packaging
  • 3.3. Pharmaceutical Vials
    • 3.3.1. Types of Fabrication Materials Used for Vials
      • 3.3.1.1. Glass Vials
      • 3.3.1.2. Plastic Vials
    • 3.3.2. Vial Caps
  • 3.4. Innovation in Pharmaceutical Vials

4. MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Pharmaceutical Vials: Overall Market Landscape
    • 4.2.1. Analysis by Type of Fabrication Material Used (Container)
    • 4.2.2. Analysis by Type of Fabrication Material Used (Closure)
    • 4.2.3. Analysis by Volume of Vial
    • 4.2.4. Analysis by Type of Vial Cap
    • 4.2.5. Analysis by Sterilization Status
    • 4.2.6. Analysis by Type of Product
    • 4.2.7. Analysis by Compatible Drug Class
    • 4.2.8. Analysis by Type of Formulation Stored
  • 4.3. Pharmaceutical Vials: List of Manufacturers
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Location of Headquarters
    • 4.3.4. Leading Manufacturers: Analysis by Number of Products

5. COMPANY COMPETITIVENESS ANALYSIS

  • 5.1. Chapter Overview
  • 5.2. Assumptions and Key Parameters
  • 5.3. Methodology
  • 5.4. Pharmaceutical Vials: Company Competitiveness Analysis
    • 5.4.1. Company Competitiveness: Small Manufacturers
    • 5.4.2. Company Competitiveness: Mid-sized Manufacturers
    • 5.4.3. Company Competitiveness: Large Manufacturers
    • 5.4.4. Company Competitiveness: Very Large Manufacturers

6. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN NORTH AMERICA

  • 6.1. Chapter Overview
  • 6.2. Corning
    • 6.2.1. Company Overview
    • 6.2.2. Financial Information
    • 6.2.3. Pharmaceutical Vials Portfolio
    • 6.2.4. Recent Developments and Future Outlook
  • 6.3. DWK Life Sciences
    • 6.3.1. Company Overview
    • 6.3.2. Pharmaceutical Vials Portfolio
    • 6.3.3. Recent Developments and Future Outlook
  • 6.4. Pacific Vial Manufacturing
    • 6.4.1. Company Overview
    • 6.4.2. Pharmaceutical Vials Portfolio
    • 6.4.3. Recent Developments and Future Outlook
  • 6.5. Thermo Fischer Scientific
    • 6.5.1. Company Overview
    • 6.5.2. Financial Information
    • 6.5.3. Pharmaceutical Vials Portfolio
    • 6.5.4. Recent Developments and Future Outlook
  • 6.6. Worldwide Glass Resources
    • 6.6.1. Company Overview
    • 6.6.2. Pharmaceutical Vials Portfolio
    • 6.6.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN EUROPE

  • 7.1. Chapter Overview
  • 7.2. Gerresheimer
    • 7.2.1. Company Overview
    • 7.2.2. Financial Information
    • 7.2.3. Pharmaceutical Vials Portfolio
    • 7.2.4. Recent Developments and Future Outlook
  • 7.3. Origin Pharma Packaging
    • 7.3.1. Company Overview
    • 7.3.2. Pharmaceutical Vials Portfolio
    • 7.3.3. Recent Developments and Future Outlook
  • 7.4. SCHOTT
    • 7.4.1. Company Overview
    • 7.4.2. Financial Information
    • 7.4.3. Pharmaceutical Vials Portfolio
    • 7.4.4. Recent Developments and Future Outlook
  • 7.5. SGD Pharma
    • 7.5.1. Company Overview
    • 7.5.2. Financial Information
    • 7.5.3. Pharmaceutical Vials Portfolio
    • 7.5.4. Recent Developments and Future Outlook
  • 7.6. Stevanato Group
    • 7.6.1. Company Overview
    • 7.6.2. Pharmaceutical Vials Portfolio
    • 7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN ASIA PACIFIC

  • 8.1. Chongqing Zhengchuan Pharmaceutical Packaging
    • 8.1.1. Company Overview
    • 8.1.2. Pharmaceutical Vials Portfolio
    • 8.1.3. Recent Developments and Future Outlook
  • 8.2. Danyang Xianghe Pharmaceutical Packaging
    • 8.2.1. Company Overview
    • 8.2.2. Pharmaceutical Vials Portfolio
    • 8.2.3. Recent Developments and Future Outlook
  • 8.3. Ningbo Zhengli Pharmaceutical Packaging
    • 8.3.1. Company Overview
    • 8.3.2. Pharmaceutical Vials Portfolio
    • 8.3.3. Recent Developments and Future Outlook
  • 8.4. Nipro
    • 8.4.1. Company Overview
    • 8.4.2. Financial Information
    • 8.4.3. Pharmaceutical Vials Portfolio
    • 8.4.4. Recent Developments and Future Outlook
  • 8.5. Shandong Pharmaceutical Glass
    • 8.5.1. Company Overview
    • 8.5.2. Pharmaceutical Vials Portfolio
    • 8.5.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Pharmaceutical Vials: List of Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Type of Fabrication Material Used
    • 9.3.5. Analysis by Sterilization Status
    • 9.3.6. Analysis by Type of Partner
    • 9.3.7. Most Active Players: Analysis by Number of Partnerships
    • 9.3.8. Analysis by Geography
      • 9.3.8.1. Region-wise Distribution
      • 9.3.8.2. Country-wise Distribution

10. UPCOMING TRENDS IN PHARMACEUTICAL PACKAGING

  • 10.1. Chapter Overview
  • 10.2. Preference for Self-medication of Drugs, Through the Use of Modern Drug Delivery Devices
  • 10.3. Development of Improved Packaging Components and Efforts to Optimize Manufacturing Costs
  • 10.4. Availability of Modular Facilities
  • 10.5. Growing Demand and Preference for Personalized Therapies
  • 10.6. Rise in Provisions for Automating Fill / Finish Operations
  • 10.7. Surge in Partnership Activity
  • 10.8. Increase in Initiatives Undertaken by Industry Stakeholders in Developing Regions
  • 10.9. Concluding Remarks

11. DEMAND ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Global Demand for Pharmaceutical Vials, Till 2035
    • 11.3.1. Analysis by Type of Fabrication Material Used
      • 11.3.1.1. Global Demand for Pharmaceutical Glass Vials, Till 2035
      • 11.3.1.2. Global Demand for Pharmaceutical Plastic Vials, Till 2035
    • 11.3.2. Analysis by Sterilization Status
      • 11.3.2.1. Global Demand for Unsterilized Pharmaceutical Vials, Till 2035
      • 11.3.2.2. Global Demand for Pre-sterilized Pharmaceutical Vials, Till 2035
    • 11.3.3. Analysis by Geography
      • 11.3.3.1. Demand for Pharmaceutical Vials in North America, Till 2035
      • 11.3.3.2. Demand for Pharmaceutical Vials in Europe, Till 2035
      • 11.3.3.3. Demand for Pharmaceutical Vials in Asia Pacific, Till 2035
      • 11.3.3.4. Demand for Pharmaceutical Vials in Middle East and North Africa, Till 2035
      • 11.3.3.5. Demand for Pharmaceutical Vials in Latin America, Till 2035
      • 11.3.3.6. Demand for Pharmaceutical Vials in Rest of the World, Till 2035
  • 11.4. Concluding Remarks

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Forecast Methodology and Key Assumptions
  • 12.3. Global Pharmaceutical Vials Market, Till 2035
    • 12.3.1. Pharmaceutical Vials Market : Distribution by Type of Fabrication Material Used
      • 12.3.1.1. Pharmaceutical Glass Vials Market, Till 2035
      • 12.3.1.2. Pharmaceutical Plastic Vials Market, Till 2035
    • 12.3.2. Pharmaceutical Vials Market : Distribution by Sterilization Status
      • 12.3.2.1. Unsterilized Pharmaceutical Vials Market, Till 2035
      • 12.3.2.2. Pre-sterilized Pharmaceutical Vials Market, Till 2035
    • 12.3.3. Pharmaceutical Vials Market : Distribution by Geography
      • 12.3.3.1. Pharmaceutical Vials Market in North America, Till 2035
      • 12.3.3.2. Pharmaceutical Vials Market in Europe, Till 2035
      • 12.3.3.3. Pharmaceutical Vials Market in Asia Pacific, Till 2035
      • 12.3.3.4. Pharmaceutical Vials Market in Middle East and North Africa, Till 2035
      • 12.3.3.5. Pharmaceutical Vials Market in Latin America, Till 2035
      • 12.3.3.6. Pharmaceutical Vials Market in Rest of the World, Till 2035

13. CASE STUDY: ROBOTS IN PHARMACEUTICAL PACKAGING

  • 13.1. Chapter Overview
  • 13.2. Role of Robots in the Pharmaceutical Industry
    • 13.2.1. Key Considerations for Selecting a Robotic System
    • 13.2.2. Advantages of Robotic Systems
    • 13.2.3. Disadvantages of Robotic Systems
  • 13.3. Companies Providing Robots for Use in the Pharmaceutical Industry
  • 13.4. Companies Providing Equipment Integrated with Robotic Systems for Pharmaceutical Packaging
    • 13.4.1. Aseptic Technologies
    • 13.4.2. AST
    • 13.4.3. Bosch Packaging Technology
    • 13.4.4. Dara Pharmaceutical Packaging
    • 13.4.5. Fedegari Group
    • 13.4.6. IMA
    • 13.4.7. Steriline
    • 13.4.8. Vanrx Pharmasystems

14. CASE STUDY: PRE-STERILIZED / READY-TO-USE PHARMACEUTICAL VIALS

  • 14.1. Chapter Overview
  • 14.2. Pharmaceutical Packaging and Filling
  • 14.3. Limitations of Traditional Primary Packaging
  • 14.4. Ready-to-Use Primary Packaging
    • 14.4.1. Sterilization of Primary Packaging Material
      • 14.4.1.1. Sterilization Techniques
    • 14.4.2. Advantages of Ready-to-Use Primary Packaging
    • 14.4.3. Cost Saving Opportunities associated with Ready-To-Use Primary Packaging
    • 14.4.4. Current Demand for Ready-To-Use Primary Packaging and Key Enablers
    • 14.4.5. List of Pre-Sterilized / Ready-to-Use Pharmaceutical Vials
  • 14.5. Concluding Remarks

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

  • 16.1. Chapter Overview
  • 16.2. Company A
    • 16.2.1. Company Snapshot
    • 16.2.2. Interview Transcript: Business Development and Technology Director
  • 16.3. Company B
    • 16.3.1. Company Snapshot
    • 16.3.2. Interview Transcript: Former Project Manager of Business Development
  • 16.4. Company C
    • 16.4.1. Company Snapshot
    • 16.4.2. Interview Transcript: SiO2 Materials Science

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 3.1 Difference between Tubular and Moulded Glass Vials
  • Table 4.1 Pharmaceutical Vials: List of Products
  • Table 4.2 Pharmaceutical Vials: List of Manufacturers
  • Table 6.1 Leading Manufacturers of Pharmaceutical Vials in North America
  • Table 6.2 Corning: Company Snapshot
  • Table 6.3 Corning: Pharmaceutical Vials
  • Table 6.4 Corning: Recent Developments and Future Outlook
  • Table 6.5 DWK Life Sciences: Company Snapshot
  • Table 6.6 DWK Life Sciences: Pharmaceutical Vials
  • Table 6.7 DWK Life Sciences: Recent Developments and Future Outlook
  • Table 6.8 Pacific Vial Manufacturing: Company Snapshot
  • Table 6.9 Pacific Vial Manufacturing: Pharmaceutical Vials
  • Table 6.10 Thermo Fisher Scientific: Company Snapshot
  • Table 6.11 Thermo Fisher Scientific: Pharmaceutical Vials
  • Table 6.12 Thermo Fisher Scientific: Recent Developments and Future Outlook
  • Table 6.13 Worldwide Glass Resources: Company Snapshot
  • Table 6.14 Worldwide Glass Resources: Pharmaceutical Vials
  • Table 7.1 Leading Manufacturers of Pharmaceutical Vials in Europe
  • Table 7.2 Gerresheimer: Company Snapshot
  • Table 7.3 Gerresheimer: Pharmaceutical Vials
  • Table 7.4 Gerresheimer: Recent Developments and Future Outlook
  • Table 7.5 Origin Pharma Packaging: Company Snapshot
  • Table 7.6 Origin Pharma Packaging: Pharmaceutical Vials
  • Table 7.7 SCHOTT: Company Snapshot
  • Table 7.8 SCHOTT: Pharmaceutical Vials
  • Table 7.9 SCHOTT: Recent Developments and Future Outlook
  • Table 7.10 SGD Pharma: Company Snapshot
  • Table 7.11 SGD Pharma: Pharmaceutical Vials
  • Table 7.12 SGD Pharma: Recent Developments and Future Outlook
  • Table 7.13 Stevanato Group: Company Snapshot
  • Table 7.14 Stevanato Group: Pharmaceutical Vials
  • Table 7.15 Stevanato Group: Recent Developments and Future Outlook
  • Table 8.1 Leading Manufacturers of Pharmaceutical Vials in Asia Pacific
  • Table 8.2 Chongqing Zhengchuan Pharmaceutical Packaging: Company Snapshot
  • Table 8.3 Chongqing Zhengchuan Pharmaceutical Packaging: Pharmaceutical Vials
  • Table 8.4 DANYANG XIANGHE PHARMACEUTICAL PACKAGING: Company Snapshot
  • Table 8.5 DANYANG XIANGHE PHARMACEUTICAL PACKAGING: Pharmaceutical Vials
  • Table 8.6 Ningbo Zhengli Pharmaceutical Packaging: Company Snapshot
  • Table 8.7 Ningbo Zhengli Pharmaceutical Packaging: Pharmaceutical Vials
  • Table 8.8 Ningbo Zhengli Pharmaceutical Packaging: Recent Developments and Future Outlook
  • Table 8.9 Nipro: Company Snapshot
  • Table 8.10 Nipro: Pharmaceutical Vials
  • Table 8.11 Nipro: Recent Developments and Future Outlook
  • Table 8.12 Shandong Pharmaceutical Glass: Company Snapshot
  • Table 8.13 Shandong Pharmaceutical Glass: Pharmaceutical Vials
  • Table 9.1 Pharmaceutical Vials: Partnerships and Collaborations, Since 2015
  • Table 12.1 Tiered Pricing Structure of Prices of Pharmaceutical Vials across Different Geographies
  • Table 13.1 List of Pharmaceutical Robotics Manufacturers
  • Table 13.2 Aseptic Technologies: Company Overview
  • Table 13.3 Aseptic Technologies: Key Specifications of Crystal L1 Robot Line
  • Table 13.4 Aseptic Technologies: Key Specifications of Crystal SL1 Robot Line
  • Table 13.5 AST: Company Overview
  • Table 13.6 AST: Key Specifications of ASEPTiCell
  • Table 13.7 AST: Key Specifications of GENiSYS R
  • Table 13.8 AST: Key Specifications of GENiSYS C
  • Table 13.9 AST: Key Specifications of GENiSYS Lab
  • Table 13.10 Bosch Packaging Technology: Company Overview
  • Table 13.11 Bosch Packaging Technology: Key Specifications of ATO
  • Table 13.12 Dara Pharmaceutical Equipment: Company Overview
  • Table 13.13 Dara Pharmaceutical Equipment: Key Specifications of SYX-E Cartridge + RABS
  • Table 13.14 Fedegari Group: Company Overview
  • Table 13.15 Fedegari Group: Key Specifications of Fedegari Isolator
  • Table 13.16 IMA: Company Overview
  • Table 13.17 IMA: Key Specifications of INJECTA
  • Table 13.18 IMA: Key Specifications of STERI LIF3
  • Table 13.19 Steriline: Company Overview
  • Table 13.20 Steriline: Key Specifications of Robotic Nest Filling Machine
  • Table 13.21 Steriline: Key Specifications of Robotic Vial Filling Machine
  • Table 13.22 Steriline: Key Specifications of Robotic Vial Capping Machine
  • Table 13.23 Vanrx Pharmasystems: Company Overview
  • Table 13.24 Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
  • Table 13.25 Vanrx Pharmasystems: Key Specifications of SA25 Aseptic Filling Workcell
  • Table 14.1 Compatibility of Polymers with Ethylene Oxide Sterilization
  • Table 14.2 Advantages and Disadvantages of Different Sterilization Techniques
  • Table 14.3 List of Pre-sterilized / Ready-to-Use Pharmaceutical Vials
  • Table 16.1 Aseptic Technologies: Company Snapshot
  • Table 16.2 PYRAMID Laboratories: Company Snapshot
  • Table 16.3 SiO2 Materials Science: Company Snapshot
  • Table 17.1 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Container)
  • Table 17.2 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Closure)
  • Table 17.3 Pharmaceutical Vials: Distribution by Volume of Vial
  • Table 17.4 Pharmaceutical Vials: Distribution by Type of Vial Cap
  • Table 17.5 Pharmaceutical Vials: Distribution by Sterilization Status
  • Table 17.6 Pharmaceutical Vials: Distribution by Type of Product
  • Table 17.7 Pharmaceutical Vials: Distribution by Compatible Drug Class
  • Table 17.8 Pharmaceutical Vials: Distribution by Type of Formulation Stored
  • Table 17.9 Pharmaceutical Vials Manufacturers: Distribution by Year of Establishment
  • Table 17.10 Pharmaceutical Vials Manufacturers: Distribution by Company Size
  • Table 17.11 Pharmaceutical Vials Manufacturers: Distribution by Location of Headquarters
  • Table 17.12 Leading Manufacturers: Distribution by Number of Products
  • Table 17.13 Corning: Annual Revenues, Since 2016 (USD Billion)
  • Table 17.14 Thermo Fisher Scientific: Annual Revenues, Since 2016 (USD Billion)
  • Table 17.15 Gerresheimer: Annual Revenues, Since 2016 (EUR Billion)
  • Table 17.16 SCHOTT: Annual Revenues, Since 2016 (EUR Billion)
  • Table 17.17 Nipro: Annual Revenues, Since 2016 (JPY Billion)
  • Table 17.18 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2015
  • Table 17.19 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 17.20 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
  • Table 17.21 Partnerships and Collaborations: Distribution by Type of Fabrication Material Used
  • Table 17.22 Partnerships and Collaborations: Year-wise Trend by Type of Fabrication Material Used
  • Table 17.23 Partnerships and Collaborations: Distribution by Sterilization Status
  • Table 17.24 Partnerships and Collaborations: Year-wise Trend by Sterilization Status
  • Table 17.25 Partnerships and Collaborations: Distribution by Analysis by Type of Partner
  • Table 17.26 Partnerships and Collaborations: Year-wise Trend by Analysis by Type of Partner
  • Table 17.27 Most Active Players: Distribution by Number of Partnerships
  • Table 17.28 Partnerships and Collaborations: Distribution by Region (Continent-wise)
  • Table 17.29 Partnerships and Collaborations: Distribution by Region (Country-wise)
  • Table 17.30 Global Demand for Pharmaceutical Vials, Till 2035 (Billion Units)
  • Table 17.31 Global Demand for Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Billion Units)
  • Table 17.32 Global Demand for Pharmaceutical Glass Vials, Till 2035 (Billion Units)
  • Table 17.33 Global Demand for Pharmaceutical Plastic Vials, Till 2035 (Billion Units)
  • Table 17.34 Global Demand for Pharmaceutical Vials: Distribution by Sterilization Status (Billion Units)
  • Table 17.35 Global Demand for Unsterilized Pharmaceutical Vials, Till 2035 (Billion Units)
  • Table 17.36 Global Demand for Pre-sterilized Pharmaceutical Vials, Till 2035 (Billion Units)
  • Table 17.37 Global Demand for Pharmaceutical Vials: Distribution by Geography
  • Table 17.38 Demand for Pharmaceutical Vials in North America, Till 2035 (Billion Units)
  • Table 17.39 Demand for Pharmaceutical Vials in Europe, Till 2035 (Billion Units)
  • Table 17.40 Demand for Pharmaceutical Vials in Asia Pacific, Till 2035 (Billion Units)
  • Table 17.41 Demand for Pharmaceutical Vials in Middle East and North Africa, Till 2035 (Billion Units)
  • Table 17.42 Demand for Pharmaceutical Vials in Latin America, Till 2035 (Billion Units)
  • Table 17.43 Demand for Pharmaceutical Vials in Rest of the World, Till 2035 (Billion Units)
  • Table 17.44 Global Pharmaceutical Vials Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.45 Pharmaceutical Vials: Likely Growth Scenarios
  • Table 17.46 Pharmaceutical Vials Market: Distribution by Type of Fabrication Material Used, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.47 Pharmaceutical Glass Vials Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.48 Pharmaceutical Plastic Vials Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.49 Pharmaceutical Vials Market: Distribution by Sterilization Status, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.50 Unsterilized Pharmaceutical Vials Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.51 Pre-sterilized Pharmaceutical Vials Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.52 Pharmaceutical Vials Market: Distribution by Geography, Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.53 Pharmaceutical Vials Market in North America, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.54 Pharmaceutical Vials Market in Europe, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.55 Pharmaceutical Vials Market in Asia-Pacific, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.56 Pharmaceutical Vials Market in Middle East and North Africa, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.57 Pharmaceutical Vials Market in Latin America, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 17.58 Pharmaceutical Vials Market in Rest of the World, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)

List of Figures

  • Figure 3.1 Advantages of Pharmaceutical Packaging
  • Figure 3.2 Types of Pharmaceutical Packaging
  • Figure 3.3 Advantages of Glass Vials
  • Figure 3.4 Innovation in Pharmaceutical Packaging and Value Chain
  • Figure 4.1 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Container)
  • Figure 4.2 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Closure)
  • Figure 4.3 Pharmaceutical Vials: Distribution by Volume of Vial
  • Figure 4.4 Pharmaceutical Vials: Distribution by Type of Vial Cap
  • Figure 4.5 Pharmaceutical Vials: Distribution by Sterilization Status
  • Figure 4.6 Pharmaceutical Vials: Distribution by Type of Product
  • Figure 4.7 Pharmaceutical Vials: Distribution by Compatible Drug Class
  • Figure 4.8 Pharmaceutical Vials: Distribution by Type of Formulation Stored
  • Figure 4.9 Pharmaceutical Vials Manufacturers: Distribution by Year of Establishment
  • Figure 4.10 Pharmaceutical Vials Manufacturers: Distribution by Company Size
  • Figure 4.11 Pharmaceutical Vials Manufacturers: Distribution by Location of Headquarters
  • Figure 4.12 Leading Manufacturers: Distribution by Number of Products
  • Figure 5.1 Company Competitiveness Analysis: Small Manufacturers
  • Figure 5.2 Company Competitiveness Analysis: Mid-sized Manufacturers
  • Figure 5.3 Company Competitiveness Analysis: Large Manufacturers
  • Figure 5.4 Company Competitiveness Analysis: Very Large Manufacturers
  • Figure 6.1 Corning: Annual Revenues, Since 2016 (USD Billion)
  • Figure 6.2 Thermo Fisher Scientific: Annual Revenues, Since 2016 (USD Billion)
  • Figure 7.1 Gerresheimer: Annual Revenues, Since 2016 (EUR Billion)
  • Figure 7.2 SCHOTT: Annual Revenues, Since 2016 (EUR Billion)
  • Figure 8.1 Nipro: Annual Revenues, Since 2016 (JPY Billion)
  • Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2015
  • Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 9.3 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
  • Figure 9.4 Partnerships and Collaborations: Distribution by Type of Fabrication Material Used
  • Figure 9.5 Partnerships and Collaborations: Year-wise Trend by Type of Fabrication Material Used
  • Figure 9.6 Partnerships and Collaborations: Distribution by Sterilization Status
  • Figure 9.7 Partnerships and Collaborations: Year-wise Trend by Sterilization Status
  • Figure 9.8 Partnerships and Collaborations: Distribution by Analysis by Type of Partner
  • Figure 9.9 Partnerships and Collaborations: Year-wise Trend by Analysis by Type of Partner
  • Figure 9.10 Most Active Players: Distribution by Number of Partnerships
  • Figure 9.11 Partnerships and Collaborations: Distribution by Region (Continent-wise)
  • Figure 9.12 Partnerships and Collaborations: Distribution by Region (Country-wise)
  • Figure 10.1 Upcoming Trends Related to Pharmaceutical Packaging
  • Figure 10.2 Future Growth Opportunities of Innovative Pharmaceutical Packaging based on Recent Trends
  • Figure 11.1 Global Demand for Pharmaceutical Vials, Till 2035 (Billion Units)
  • Figure 11.2 Global Demand for Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Billion Units)
  • Figure 11.3 Global Demand for Pharmaceutical Glass Vials, Till 2035 (Billion Units)
  • Figure 11.4 Global Demand for Pharmaceutical Plastic Vials, Till 2035 (Billion Units)
  • Figure 11.5 Global Demand for Pharmaceutical Vials: Distribution by Sterilization Status (Billion Units)
  • Figure 11.6 Global Demand for Unsterilized Pharmaceutical Vials, Till 2035 (Billion Units)
  • Figure 11.7 Global Demand for Pre-sterilized Pharmaceutical Vials, Till 2035 (Billion Units)
  • Figure 11.8 Global Demand for Pharmaceutical Vials: Distribution by Geography
  • Figure 11.9 Demand for Pharmaceutical Vials in North America, Till 2035 (Billion Units)
  • Figure 11.10 Demand for Pharmaceutical Vials in Europe, Till 2035 (Billion Units)
  • Figure 11.11 Demand for Pharmaceutical Vials in Asia Pacific, Till 2035 (Billion Units)
  • Figure 11.12 Demand for Pharmaceutical Vials in Middle East and North Africa, Till 2035 (Billion Units)
  • Figure 11.13 Demand for Pharmaceutical Vials in Latin America, Till 2035 (Billion Units)
  • Figure 11.14 Demand for Pharmaceutical Vials in Rest of the World, Till 2035 (Billion Units)
  • Figure 12.1 Global Pharmaceutical Vials Market, Till 2035 (USD Billion)
  • Figure 12.2 Pharmaceutical Vials: Likely Growth Scenarios
  • Figure 12.3 Pharmaceutical Vials Market : Distribution by Type of Fabrication Material Used (USD Billion)
  • Figure 12.4 Pharmaceutical Glass Vials Market, Till 2035 (USD Billion)
  • Figure 12.5 Pharmaceutical Plastic Vials Market, Till 2035 (USD Billion)
  • Figure 12.6 Pharmaceutical Vials Market : Distribution by Sterilization Status (USD Billion)
  • Figure 12.7 Unsterilized Pharmaceutical Vials Market, Till 2035 (USD Billion)
  • Figure 12.8 Pre-sterilized Pharmaceutical Vials Market, Till 2035 (USD Billion)
  • Figure 12.9 Pharmaceutical Vials Market : Distribution by Geography (USD Billion)
  • Figure 12.10 Pharmaceutical Vials Market in North America, Till 2035 (USD Billion)
  • Figure 12.11 Pharmaceutical Vials Market in Europe, Till 2035 (USD Billion)
  • Figure 12.12 Pharmaceutical Vials Market in Asia-Pacific, Till 2035 (USD Billion)
  • Figure 12.13 Pharmaceutical Vials Market in Middle East and North Africa, Till 2035 (USD Billion)
  • Figure 12.14 Pharmaceutical Vials Market in Latin America, Till 2035 (USD Billion)
  • Figure 12.15 Pharmaceutical Vials Market in Rest of the World, Till 2035 (USD Billion)
  • Figure 13.1 Key Considerations for Selecting a Robotic System
  • Figure 13.2 Advantages Associated with Use of Robotic Systems in Pharmaceutical Manufacturing
  • Figure 14.1 Traditional Aseptic Pharmaceutical Filling
  • Figure 14.2 Ready-to-Use Enabled Flexible, Aseptic Processing
  • Figure 14.3 Advantages of Ready-to-Use Platform
  • Figure 14.4 Cost Comparison of Ready-to-Use and Conventional Container Systems
  • Figure 14.5 Drivers of Ready-to-Use Platform
  • Figure 16.1 Concluding Remarks: Overall Market Landscape
  • Figure 16.2 Concluding Remarks: Partnerships and Collaborations
  • Figure 16.3 Concluding Remarks: Global Demand for Pharmaceutical Vials
  • Figure 16.4 Concluding Remarks: Market Forecast